Radiopharm Theranostics (ASX:RAD) has announced that Imperial College London has released additional data related to the F-18 Pivalate (RAD 101) Phase 2a imaging trial in patients with brain metastases. …
Additional data released from positive imaging trial in brain metastases
November 23, 2022 Latest NewsAustralian Biotech
Latest Video
New Stories
-
Draft 'National Health Genomics Policy Framework' out for consultation
July 3, 2025 - - Latest News -
MedAdvisor announces agreement confirming the sale of Australian business
July 3, 2025 - - Latest News -
GBMA announces planned departure of long-standing CEO
July 2, 2025 - - Latest News -
Neurizon announces global agreement with Elanco for the commercialisation of NUZ-001
July 2, 2025 - - Australian Biotech -
Prescient Therapeutics opens share purchase plan
July 2, 2025 - - Australian Biotech -
Amplia Therapeutics announces additional confirmed partial response recorded in ACCENT trial
July 2, 2025 - - Australian Biotech -
Island Pharmaceuticals announces the appointment of new chair
July 2, 2025 - - Australian Biotech